Long-Term Follow-Up Study of Patients With Osteoarthritis of the Knee Treated With UBX0101 or Placebo

Stopped Inability to achieve primary or secondary study objectives

Conditions

• Knee Osteoarthritis

Interventions

• DRUG: UBX0101 or placebo

Sponsor

Unity Biotechnology, Inc.